Breast cancer drug is REJECTED by NHS watchdog – as Loose Women star brands decision ‘heartbreaking’
A LAST-DITCH breast cancer drug has been formally rejected by the NHS watchdog due to its asking price.In clinical trials Enhertu, known as trastuzumab deruxtecan,…